Long-Term Survival with Ibrutinib Therapy in Elderly Patients with Newly Diagnosed Primary Central Nervous System Lymphoma

Primary central nervous system lymphoma (PCNSL) carries a dismal prognosis in elderly patients above 70 years of age with a median overall survival of 6 months. Novel therapeutic agents are urgently needed to improve survival outcomes in this age group. We describe the clinical presentation, diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuhlman, Justin J, Alhaj Moustafa, Muhamad, Jiang, Liuyan, Wang, Jing, Gupta, Vivek, Tun, Han W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015786/
https://www.ncbi.nlm.nih.gov/pubmed/35444484
http://dx.doi.org/10.2147/BLCTT.S360442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015786/
https://www.ncbi.nlm.nih.gov/pubmed/35444484
http://dx.doi.org/10.2147/BLCTT.S360442

Ejemplares similares